Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.

"Disclosures Dr Jones reports significant: investigator, proctor, and consultant for Medtronic. Dr McElhinney reports significant: investigator, proctor, and consultant for Medtronic. Dr Vincent reports modest: consultant and proctor for Medtronic. Dr Hellenbrand reports significant: former investigator, consultant, and proctor for Medtronic. Dr Cheatham reports significant: consultant, proctor, principal investigator for Medtronic; Consultant for NuMED. Dr Berman reports modest: consultant for Medtronic. Dr Zahn reports significant: former investigator, current proctor, and current consultant for Medtronic. S. Weng reports significant: employee and shareholder of Medtronic. The other authors report no conflicts."

"Sources of Funding This work was supported by Medtronic (Mounds View, MN)."

"Registration:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00740870."